ReviewDrug design, development and therapy2018

Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era.

Nicola Squillace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.